Literature DB >> 16864563

EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology.

W Zhang1, M Doherty.   

Abstract

The quality of the EULAR recommendations for the management of hip and knee osteoarthritis (OA) was evaluated using a validated instrument. The quality and methods were compared with other guidelines and recommendations. EULAR recommendations were found to be among the best for overall quality. They show strengths with respect to scope, rigour of development, and clarity, but weaknesses with respect to stakeholder involvement, applicability, and editorial independence. However, a principal strength is their attempt to fill the gap between guidelines based solely on either research evidence or expert opinion. The methods used to synthesise research evidence (systematic review) and expert opinion (Delphi exercise) are robust. Strength of recommendation, based on combined consideration of research evidence, clinical expertise, and perceived patient preference, is valid and approaches the true essence of "evidence based practice" that considers each of these different forms of evidence.

Entities:  

Mesh:

Year:  2006        PMID: 16864563      PMCID: PMC2579446          DOI: 10.1136/bjsm.2004.016840

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  24 in total

1.  Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines.

Authors: 
Journal:  Arthritis Rheum       Date:  2000-09

Review 2.  Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensus.

Authors:  E Roddy; W Zhang; M Doherty; N K Arden; J Barlow; F Birrell; A Carr; K Chakravarty; J Dickson; E Hay; G Hosie; M Hurley; K M Jordan; C McCarthy; M McMurdo; S Mockett; S O'Reilly; G Peat; A Pendleton; S Richards
Journal:  Rheumatology (Oxford)       Date:  2004-09-07       Impact factor: 7.580

Review 3.  EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; N Arden; B Bannwarth; J Bijlsma; K-P Gunther; H J Hauselmann; G Herrero-Beaumont; K Jordan; P Kaklamanis; B Leeb; M Lequesne; S Lohmander; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; B Swoboda; R Varatojo; G Verbruggen; I Zimmermann-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-10-07       Impact factor: 19.103

Review 4.  Ottawa panel evidence-based clinical practice guidelines for therapeutic exercises and manual therapy in the management of osteoarthritis.

Authors: 
Journal:  Phys Ther       Date:  2005-09

5.  Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries.

Authors:  B Mazières; N Scmidely; H J Hauselmann; E Martin-Mola; U Serni; A A Verbruggen; M Le Bars
Journal:  Ann Rheum Dis       Date:  2005-02-11       Impact factor: 19.103

6.  ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; R Burgos-Vargas; E Collantes; J C Davis; B Dijkmans; M Dougados; P Géher; R D Inman; M A Khan; T K Kvien; M Leirisalo-Repo; I Olivieri; K Pavelka; J Sieper; G Stucki; R D Sturrock; S van der Linden; D Wendling; H Böhm; B J van Royen; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

7.  Evidence-based clinical guidelines: a new system to better determine true strength of recommendation.

Authors:  Edward Roddy; Weiya Zhang; Michael Doherty; Nigel K Arden; Julie Barlow; Fraser Birrell; Alison Carr; Kuntal Chakravarty; John Dickson; Elaine Hay; Gillian Hosie; Michael Hurley; Kelsey M Jordan; Christopher McCarthy; Marion McMurdo; Simon Mockett; Sheila O'Reilly; George Peat; Adrian Pendleton; Selwyn Richards
Journal:  J Eval Clin Pract       Date:  2006-06       Impact factor: 2.431

8.  North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-08-22

9.  Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions.

Authors:  R B Haynes; D L Sackett; J M Gray; D J Cook; G H Guyatt
Journal:  ACP J Club       Date:  1996 Nov-Dec

10.  Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36.

Authors:  O Svensson; M Malmenäs; L Fajutrao; E M Roos; L S Lohmander
Journal:  Ann Rheum Dis       Date:  2005-11-03       Impact factor: 19.103

View more
  14 in total

Review 1.  Effectiveness of platelet-rich plasma in the management of hip osteoarthritis: a systematic review and meta-analysis.

Authors:  Ivan Medina-Porqueres; Miguel Ortega-Castillo; Alfonso Muriel-Garcia
Journal:  Clin Rheumatol       Date:  2020-06-30       Impact factor: 2.980

2.  Prevalence of radiographic primary hip and knee osteoarthritis in a representative Central European population.

Authors:  Gábor Horváth; Gabriella Koroknai; Barnabás Ács; Péter Than; Árpád Bellyei; Tamás Illés
Journal:  Int Orthop       Date:  2010-06-16       Impact factor: 3.075

Review 3.  Systematic review of the prevalence of radiographic primary hip osteoarthritis.

Authors:  Simon Dagenais; Shawn Garbedian; Eugene K Wai
Journal:  Clin Orthop Relat Res       Date:  2008-11-27       Impact factor: 4.176

4.  The diagnostic performance of radiography for detection of osteoarthritis-associated features compared with MRI in hip joints with chronic pain.

Authors:  Li Xu; Daichi Hayashi; Ali Guermazi; David J Hunter; Ling Li; Anton Winterstein; Klaus Bohndorf; Frank W Roemer
Journal:  Skeletal Radiol       Date:  2013-07-11       Impact factor: 2.199

5.  EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; B F Leeb; L Alekseeva; N K Arden; J W Bijlsma; F Dinçer; K Dziedzic; H J Häuselmann; G Herrero-Beaumont; P Kaklamanis; S Lohmander; E Maheu; E Martín-Mola; K Pavelka; L Punzi; S Reiter; J Sautner; J Smolen; G Verbruggen; I Zimmermann-Górska
Journal:  Ann Rheum Dis       Date:  2006-10-17       Impact factor: 19.103

Review 6.  The benefits and barriers to physical activity and lifestyle interventions for osteoarthritis affecting the adult knee.

Authors:  Jonathan Daniel Stevenson; Richard Roach
Journal:  J Orthop Surg Res       Date:  2012-03-31       Impact factor: 2.359

7.  The Efficacy and Safety of Disease-Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis-a Systematic Review and Network Meta-Analysis.

Authors:  Wei Yang; Cheng Sun; Sheng Qin He; Ji Ying Chen; Yan Wang; Qi Zhuo
Journal:  J Gen Intern Med       Date:  2021-04-12       Impact factor: 6.473

8.  Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.

Authors:  Olivier Bruyère; Nansa Burlet; Pierre D Delmas; René Rizzoli; Cyrus Cooper; Jean-Yves Reginster
Journal:  BMC Musculoskelet Disord       Date:  2008-12-16       Impact factor: 2.362

9.  The influence of computer-assisted surgery on rotational, coronal and sagittal alignment in revision total knee arthroplasty.

Authors:  Marrigje F Meijer; Martin Stevens; Alexander L Boerboom; Sjoerd K Bulstra; Inge Hf Reininga
Journal:  BMC Musculoskelet Disord       Date:  2014-03-19       Impact factor: 2.362

10.  Web-based therapeutic exercise resource center as a treatment for knee osteoarthritis: a prospective cohort pilot study.

Authors:  M Alison Brooks; John E Beaulieu; Herbert H Severson; Christa M Wille; David Cooper; Jeff M Gau; Bryan C Heiderscheit
Journal:  BMC Musculoskelet Disord       Date:  2014-05-17       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.